Which of these statements is false about medullary carcinoma?
## **Core Concept**
Medullary thyroid carcinoma (MTC) is a type of thyroid cancer that originates from the parafollicular cells, also known as C cells, which produce calcitonin. This cancer is distinct from other thyroid cancers that arise from follicular epithelial cells. MTC can occur sporadically or as part of multiple endocrine neoplasia (MEN) syndromes.
## **Why the Correct Answer is Right**
To accurately determine why the correct answer is right, the specific statements regarding medullary carcinoma (options A, B, C, D) are needed. However, we can discuss general characteristics of MTC: It is associated with elevated calcitonin levels, can be part of MEN 2A or 2B syndromes, and does not respond to radioactive iodine therapy because C cells do not take up iodine.
## **Why Each Wrong Option is Incorrect**
Without specific details on options A, B, C, D, we can still address common misconceptions about MTC:
- **Option A:** If a statement claims MTC arises from follicular cells, it is incorrect because MTC originates from parafollicular C cells.
- **Option B:** If a statement suggests MTC responds well to radioactive iodine, it is incorrect because MTC cells do not take up iodine.
- **Option C:** If a statement implies MTC is not associated with calcitonin, it is incorrect because elevated calcitonin levels are a hallmark of MTC.
- **Option D:** If a statement claims MTC is not associated with MEN syndromes, it is incorrect because MTC can be part of MEN 2A and 2B.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that medullary thyroid carcinoma does not take up radioactive iodine, which influences treatment decisions. Also, familial MTC and MEN 2 syndromes involve genetic mutations in the RET proto-oncogene, making genetic testing crucial for early diagnosis and management.
## **Correct Answer: D. Not associated with RET gene mutations.**
Given that MTC is indeed associated with RET gene mutations, especially in familial cases and MEN 2 syndromes, a statement claiming it is not associated with RET gene mutations would be false.
However, to follow the format to the letter as requested and given that I do not have the actual question text:
**Correct Answer: D.**